CAJ | 학술논문

表皮因子受体3（ ErbB3/ eER3）是表皮生长因子跨膜受体家族的成员之一。近年来证实ErbB3/ eER3与乳腺癌的发病、复发转移、化疗以及内分泌治疗的疗效密切相关，已成为非常有前景的治疗候选靶点。本文简要综述近年来 ErbB3/ eER3在乳腺癌中的研究进展。
표피인자수체3（ ErbB3/ eER3）시표피생장인자과막수체가족적성원지일。근년래증실ErbB3/ eER3여유선암적발병、복발전이、화료이급내분비치료적료효밀절상관，이성위비상유전경적치료후선파점。본문간요종술근년래 ErbB3/ eER3재유선암중적연구진전。
ErbB3 / eER3 is one member of ErbBs family. In recent years,it has been confirmed that ErbB3 / eER3 was involved in the Pathogenesis,recurrence,metastasis and the curative effect of chemotheraPy and endocrine theraPy in breast cancer. ErbB3 / eER3 has been becoming a Promising new target for breast cancer treatments. This PaPer is going to summarize the research Progress of ErbB3 / eER3 in breast cancer.